Peter A. Thompson
Director at Sionna Therapeutics, Inc. (SION)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $55.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 9SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 85,9182,469,959 held (−3%) | $44.86 | $3.9M | -89.1% |
| Jul 2SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 115,8442,555,877 held (−4%) | $45.50 | $5.3M | -89.2% |
| May 29SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 1012,671,721 held (−0%) | $44.49 | $4K | -89.0% |
| May 11SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 48,5462,916,228 held (−2%) | $44.61 | $2.2M | -89.0% |
| May 11SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 59,7672,856,461 held (−2%) | $44.58 | $2.7M | -89.0% |
| May 11SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 184,6392,671,822 held (−6%) | $46.22 | $8.5M | -89.4% |
| Apr 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 52,3972,967,722 held (−2%) | $44.68 | $2.3M | -89.0% |
| Apr 21SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 2,9482,964,774 held (−0%) | $44.52 | $131K | -89.0% |
| Apr 16SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 47,8143,482,888 held (−1%) | $44.51 | $2.1M | -89.0% |
| Apr 16SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 235,8633,247,025 held (−7%) | $44.64 | $10.5M | -89.0% |
| Apr 16SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 226,9063,020,119 held (−7%) | $45.34 | $10.3M | -89.2% |
| Feb 4SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 1,8903,559,765 held (−0%) | $44.57 | $84K | -89.0% |
| Feb 4SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 29,0633,530,702 held (−1%) | $44.58 | $1.3M | -89.0% |
| Dec 29SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 33,3563,561,655 held (−1%) | $44.55 | $1.5M | -89.0% |
| Dec 19SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 9003,595,986 held (−0%) | $44.50 | $40K | -89.0% |
| Dec 19SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 1003,595,886 held (−0%) | $44.49 | $4K | -89.0% |
| Dec 19SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 8753,595,011 held (−0%) | $44.49 | $39K | -89.0% |
| Nov 26SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 94,5833,610,376 held (−3%) | $44.54 | $4.2M | -89.0% |
| Nov 26SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 11,8903,598,486 held (−0%) | $44.60 | $530K | -89.0% |
| Nov 26SEC | SIONSionna Therapeutics, Inc. | Sell Plan | 1,6003,596,886 held (−0%) | $44.49 | $71K | -89.0% |
- Sell
Director Peter A. Thompson sold $3.9M of SION at $44.86 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Peter A. Thompson sold $5.3M of SION at $45.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Peter A. Thompson sold $4K of SION at $44.49 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Peter A. Thompson sold $2.2M of SION at $44.61 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Peter A. Thompson sold $2.7M of SION at $44.58 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Peter A. Thompson sold $8.5M of SION at $46.22 — pre-scheduled 10b5-1 plan sale.